The impact of the COVID-19 epidemic on primary care in South-eastern France: implementation of a real-time monitoring system based on regional health insurance system data

Davin-Casalena, Bérengère; Jardin, M.; Guerrera, H.; Mabille, J.; Tréhard, Hélène; Lapalus, Denis; Ménager, Céline; Nauleau, S.; Cassaro, Valmir Moratelli; Verger, Pierre; Guagliardo, Valérie

doi:10.1016/j.respe.2021.07.006

Cited by 11 publications

(7 citation statements)

References 23 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of insomnia symptoms was 23.2%. The symptom was higher in young adults than adolescents, and higher in adolescents than in children (18%, 25.3% and 25.7% insomnia in children, adolescents and young adults respectively) (Davin-Casalena et al, 2021).…”

Section: Prevalence Of Mental Health Illnessesmentioning

confidence: 86%

COVID-19 and Its Association with Psychological Health of Children, Adolescents and Young Adults

Basnet¹

2022

J. Tech. & Voc. Educ. & Train.

View full text Add to dashboard Cite

The COVID-19 pandemic has been causing a severe threat to multiple sectors, including people's psychosocial health. The main objective of this review is to identify the association of COVID-19 pandemic with the psychological health of children, adolescents and young adults. Total 18 primary studies, including most of the studies being cross sectional descriptive studies, were included in the review. The review found that the prevalence of anxiety levels among children ranges from 23.87 % to 38%. Similarly, in adolescents, it ranged from 29.27% to 31% and depression level ranges from 22.28% to 44.5 %. The prevalence of depression in young adults was found to be nearly 82 % while the prevalence of anxiety was found to be nearly 88 %.Most of the studies identified COVID-19 as major factor contributing to anxiety, depression and sleep disorders in children, adolescents and young adults. In the review, almost half of the papers described the factors associated with mental health status due to COVID-19 pandemic. The major factors to increase anxiety and depression were found to be restriction on movement, social distancing, closures of schools, little interaction with peers, educational status, smartphone and internet addiction, frequent watching, listening, or reading news related with COVID-19. Thus, efforts must be initiated to improve services within the country to overcome the increasing mental health problems in these groups. The findings of this review would be relevant for all health professionals, medical persons, and educational institutions to sensitize them about the prevalence of psychological problems among children, adolescents and young adults in terms of overcoming and addressing this pressing issue.

show abstract

Section: Prevalence Of Mental Health Illnessesmentioning

confidence: 86%

COVID-19 and Its Association with Psychological Health of Children, Adolescents and Young Adults

Basnet¹

2022

J. Tech. & Voc. Educ. & Train.

View full text Add to dashboard Cite

show abstract

“…During the pandemic and compared to the previous year, the proportion of patients with medications increased in our study and for SGLT-2 and GLP-1 a significant effect was attributable to the pandemic. Other studies observed: an increase in insulin [ 39 ] and both insulin and OAD medications [ 40 , 41 ], during the first month of pandemic as compared to the year before; a decrease in OAD during the first four months of the pandemic [ 42 ].…”

Section: Discussionmentioning

confidence: 99%

“…Reduction in follow-up visits in type 2 diabetes patients was independent of age, sex, and educational level [ 20 ]. Other studies investigated the reasons to avoid or postponed the visit during lockdown [ 3 , 40 ]. Differently from [ 20 ], we found that dropout of youngest patients, age ≤ 40 years, was the most affected by the pandemic, PAF 37%(30, 43)% though the oldest ones, age > 80 years, had the highest risk of dropout, after correcting for confounders.…”

Section: Discussionmentioning

confidence: 99%

Quality outcome of diabetes care during COVID-19 pandemic: a primary care cohort study

Gangi¹,

Lüthi

Hernàndez

et al. 2022

Acta Diabetol

View full text Add to dashboard Cite

Aim Management of diabetes care can be affected by COVID-19 pandemic control measures. This study aimed to determine the impact of the pandemic, during 17.03.2020–16.03.2021, on quality outcomes of diabetes care in general practice in Switzerland. Methods In this retrospective cohort study, diabetes mellitus patients (≥ 18 years) with at least one consultation at a general practitioner, during 17.03.2018–16.03.2019 (cohort 1) and 17.03.2019–16.03.2020 (cohort 2) were included and followed-up for two years. Quality indicators and outcomes of diabetes care, at patient and practitioner level, were compared before and during the pandemic. Logistic regression was performed to identify patient’s risk factors for dropout from follow-up. Results Data from 191 practices, 23,903 patients, cohort 1 and 25,092 patients, cohort 2, were analyzed. The fraction of patients lost to follow-up, attributable to the pandemic, was 28% (95% confidence interval: 25%, 30%). During the pandemic, compared to the previous year, regular measurement of weight, HbA1c, blood pressure and serum creatinine were less frequent and less patients per practitioner reached HbA1c and blood pressure target outcomes. Factors associated with continuity of care during the pandemic were: patient age 41–80 years, longer diabetes duration, diagnosis of hypertension or dyslipidemia, influenza vaccination during the last year. Risk factors for dropout were age > 80 and receiving only insulin as anti-diabetic medication. Conclusion A considerable quality reduction in diabetes mellitus care could be observed during the pandemic. Though the most vulnerable patients were not the most affected by the pandemic, key factors that might reduce dropout from follow-up were identified.

show abstract

“…Healthcare use has been challenged during the COVID-19 pandemic ( 1 ), particularly during the first epidemic wave and the first lockdown, which lasted from 17 March to 10 May 2020 in France ( 2 , 3 ). Two subsequent lockdowns, although less restrictive than the first one, were implemented in France to contain the second epidemic wave- from 30 October to 15 December- and the third one – from 3 April to 2 May 2021.…”

Section: Introductionmentioning

confidence: 99%

Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?

Gabet

Grave

Tuppin

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

ObjectivesThis study examines the initiation of prescribed medication treatments for cardiovascular risk (antihypertensives, lipid-lowering drugs, oral anticoagulants in atrial fibrillation, and smoking cessation medications) during the COVID-19 pandemic in the French population.MethodsFor each year between 2017 and 2021, we used the French National Insurance Database to identify the number of people with at least one reimbursement for these medications but no reimbursement in the previous 12 months. We computed incidence rate ratios (IRRs) between 2017–2019 and, respectively 2020 and 2021 using Poisson regression adjusted for age and 2017–2019 time trends. We recorded the number of lipid profile blood tests, Holter electrocardiograms, and consultations with family physicians or cardiologists.ResultsIn 2020, IRR significantly decreased for initiations of antihypertensives (−11.1%[CI95%, −11.4%;−10.8%]), lipid-lowering drugs (−5.2%[CI95%, −5.5%;−4.8%]), oral anticoagulants in atrial fibrillation (−8.6%[CI95%, −9.1%;−8.0%]), and smoking cessation medications (−50.9%[CI95%, −51.1%;−50.7%]) compared to 2017–2019. Larger decreases were found in women compared to men except for smoking cessation medications, with the sex difference increasing with age. Similar analyses comparing 2021 to 2017–2019 showed an increase in the initiation of lipid-lowering drugs (+ 11.6%[CI95%, 10.7%;12.5%]) but even lower rates for the other medications, particularly in women. In addition, the 2020 number of people visiting a family physician or cardiologist decreased by 8.4 and 7.4%. A higher decrease in these visits was observed in those over 65 years of age compared to those under 65 years of age. A greater use of teleconsultation was found in women.ConclusionThe COVID-19 pandemic heavily impacted the initiation of medication treatments for cardiovascular risk in France, particularly in women and people over 65 years.

show abstract

The impact of the COVID-19 epidemic on primary care in South-eastern France: implementation of a real-time monitoring system based on regional health insurance system data

Cited by 11 publications

References 23 publications

COVID-19 and Its Association with Psychological Health of Children, Adolescents and Young Adults

COVID-19 and Its Association with Psychological Health of Children, Adolescents and Young Adults

Quality outcome of diabetes care during COVID-19 pandemic: a primary care cohort study

Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?

Contact Info

Product

Resources

About